WMT

82.45

+0.4%↑

PG

165.27

+0.17%↑

COST

885.66

+0.97%↑

KO

65

+0.12%↑

PEP

166.25

+0.43%↑

WMT

82.45

+0.4%↑

PG

165.27

+0.17%↑

COST

885.66

+0.97%↑

KO

65

+0.12%↑

PEP

166.25

+0.43%↑

WMT

82.45

+0.4%↑

PG

165.27

+0.17%↑

COST

885.66

+0.97%↑

KO

65

+0.12%↑

PEP

166.25

+0.43%↑

WMT

82.45

+0.4%↑

PG

165.27

+0.17%↑

COST

885.66

+0.97%↑

KO

65

+0.12%↑

PEP

166.25

+0.43%↑

WMT

82.45

+0.4%↑

PG

165.27

+0.17%↑

COST

885.66

+0.97%↑

KO

65

+0.12%↑

PEP

166.25

+0.43%↑

Search

Hims & Hers Health Inc

Suletud

Sektor Tarbekaubad (kaitseaktsiad)

20.35 7.9

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

20.26

Max

20.56

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+6.83 upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

4. nov 2024

Uudiste sentiment

By Acuity

25%

75%

32 / 151 Pingereas Consumer defensive

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

Hims & Hers Health Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

14. okt 2024, 15:02 UTC

Suurimad hinnamuutused turgudel

Hims & Hers Health Shares Jump After FDA Set to Reconsider Limits on Knockoff Weight-Loss Drugs

3. okt 2024, 11:28 UTC

Suurimad hinnamuutused turgudel

Hims & Hers Health Shares Fall After FDA Removes Eli Lilly Obesity Drugs From Shortage List

4. jaan 2024, 21:15 UTC

Suurimad hinnamuutused turgudel

WeightWatchers Stock Drops 12% After Eli Lilly Launches DTC Weight-Loss Drug Service

3. okt 2024, 14:45 UTC

Peamised uudised

Eli Lilly's Weight-Loss Drugs Are No Longer in Short Supply. Bad News for Hims & Hers. -- Barrons.com

3. okt 2024, 13:12 UTC

Peamised uudised

Eli Lilly's Weight-Loss Drugs No Longer in Shortage. Bad News for Hims & Hers. -- Barrons.com

3. okt 2024, 11:45 UTC

Peamised uudised

Update: Eli Lilly's Weight-Loss Drugs No Longer in Shortage. Bad News for Hims & Hers. -- Barrons.com

3. okt 2024, 10:14 UTC

Peamised uudised

Update: Eli Lilly's Weight-Loss Drugs No Longer In Shortage. It's Bad News for These Stocks. -- Barrons.com

2. aug 2024, 17:52 UTC

Omandamised, ülevõtmised, äriostud

Hims & Hers Plan to Sell Knockoff Weight Loss Drug Looking Shaky -- Barrons.com

26. juuni 2024, 11:00 UTC

Peamised uudised
Omandamised, ülevõtmised, äriostud

The War Over Cheaper Ozempic Won't End Well for Some Investors -- Heard on the Street -- WSJ

24. mai 2024, 20:37 UTC

Tulu

The Score: Target, Nvidia, Live Nation and More Stocks That Defined the Week -- WSJ

Võrdlus sarnastega

Hinnamuutus

Hims & Hers Health Inc Prognoos

Hinnasiht

By TipRanks

6.83% tõus

12 kuu keskmine prognoos

Keskmine 21.75 USD  6.83%

Kõrge 28 USD

Madal 13 USD

Põhineb 13 Wall Streeti analüütiku instrumendi Hims & Hers Health Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

13 ratings

5

Osta

8

Hoia

0

Müü

Tehniline skoor

By Trading Central

18.325 / 22.15Toetus ja vastupanu

Lühikene perspektiiv

Very Strong Bearish Evidence

Keskpikk perspektiiv

Strong Bullish Evidence

Pikk perspektiiv

Bullish Evidence

Sentiment

By Acuity

32 / 151 Pingereas Tarbekaubad (kaitseaktsiad)

Uudiste sentiment

Väga tugevad tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

$